Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions
Keith M. Sullivan, Francis A. Farraye, Kevin L. Winthrop, David O. Willer, Peter Vink, Fernanda Tavares-Da-Silva
Dive into the research topics of 'Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions'. Together they form a unique fingerprint.